GALLEX 4 - Long-Term Extension Study to Evaluate Tesaglitazar Therapy in Patients With Type 2 Diabetes

NCT00300105 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
400
Enrollment
INDUSTRY
Sponsor class

Stopped The development program has been terminated

Conditions

Interventions

Sponsor

AstraZeneca